| Host immunomodulatory lipids created by symbionts from dietary amino acids SF Oh, T Praveena, H Song, JS Yoo, DJ Jung, D Erturk-Hasdemir, ... Nature 600 (7888), 302-307, 2021 | 72 | 2021 |
| Analysis of launch and postapproval cancer drug pricing, clinical benefit, and policy implications in the US and Europe KN Vokinger, TJ Hwang, P Daniore, CWC Lee, A Tibau, T Grischott, ... JAMA oncology 7 (9), e212026-e212026, 2021 | 57 | 2021 |
| An Overview Of Vaccine Development, Approval, And Regulation, With Implications For COVID-19: Analysis reviews the Food and Drug Administration's critical vaccine approval role … AS Kesselheim, JJ Darrow, M Kulldorff, BL Brown, M Mitra-Majumdar, ... Health Affairs 40 (1), 25-32, 2021 | 52 | 2021 |
| Medicare spending on brand-name combination medications vs their generic constituents CA Sacks, CWC Lee, AS Kesselheim, J Avorn Jama 320 (7), 650-656, 2018 | 51 | 2018 |
| Market exclusivity length for drugs with new generic or biosimilar competition, 2012–2018 BN Rome, CWC Lee, AS Kesselheim Clinical Pharmacology & Therapeutics 109 (2), 367-371, 2021 | 35 | 2021 |
| Seasonal changes in diet and chemical defense in the Climbing Mantella frog (Mantella laevigata) NA Moskowitz, AB Roland, EK Fischer, N Ranaivorazo, C Vidoudez, ... PLoS One 13 (12), e0207940, 2018 | 26 | 2018 |
| Cost to medicare of delayed adalimumab biosimilar availability CWC Lee, M Najafzadeh, AS Kesselheim, A Sarpatwari Clinical Pharmacology & Therapeutics 110 (4), 1050-1056, 2021 | 20 | 2021 |
| Clinical benefit and expedited approval of cancer drugs in the United States, European Union, Switzerland, Japan, Canada, and Australia TJ Hwang, AS Kesselheim, A Tibau, CWC Lee, KN Vokinger JCO Oncology Practice 18 (9), e1522-e1532, 2022 | 19 | 2022 |
| Factors associated with generic drug uptake in the United States, 2012 to 2017 BN Rome, CWC Lee, JJ Gagne, AS Kesselheim Value in Health 24 (6), 804-811, 2021 | 11 | 2021 |
| Public-sector contributions to novel biologic drugs RK Nayak, CWC Lee, J Avorn, AS Kesselheim JAMA Internal Medicine 181 (11), 1522-1525, 2021 | 9 | 2021 |
| Associations between patient-reported outcome measures of asthma control and psychosocial symptoms CWC Lee, FF Holder-Niles, L Haynes, J Chan Yuen, CJ Rea, K Conroy, ... Clinical pediatrics 58 (3), 307-312, 2019 | 6 | 2019 |
| Clinical development times for biosimilars in the United States CWC Lee, AS Kesselheim, A Sarpatwari Mayo Clinic Proceedings 95 (10), 2152-2154, 2020 | 4 | 2020 |
| Estimated Medicaid spending on original and citrate-free adalimumab from 2014 through 2021 J Wang, CWC Lee, AS Kesselheim, BN Rome JAMA Internal Medicine 183 (3), 275-276, 2023 | 3 | 2023 |
| Origins and ownership of remdesivir: implications for pricing CWC Lee, JJ Darrow, J Avorn, AS Kesselheim The Journal of Law, Medicine & Ethics 48 (3), 613-618, 2020 | 3 | 2020 |
| Characteristics of postmarketing studies for vaccines approved by the US Food and Drug Administration, 2006-2020 O Moneer, CWC Lee, J Avorn, AS Kesselheim JAMA Network Open 4 (4), e218530-e218530, 2021 | 2 | 2021 |
| Variations in Generic Combination Opioid Use Across State Medicaid Programs CWC Lee, AS Kesselheim, J Avorn Journal of General Internal Medicine 36, 3240-3242, 2021 | | 2021 |
| DRUG CHARACTERISTICS ASSOCIATED WITH GENERIC UPTAKE AFTER LOSS OF MARKET EXCLUSIVITY BN Rome, CWC Lee, AS Kesselheim JOURNAL OF GENERAL INTERNAL MEDICINE 35 (SUPPL 1), S97-S97, 2020 | | 2020 |
| Pivotal trial endpoints and prices of cancer drugs in the US and Europe. KN Vokinger, P Daniore, TJ Hwang, CWC Lee, AS Kesselheim Journal of Clinical Oncology 38 (15_suppl), 2077-2077, 2020 | | 2020 |
| Launch prices and price developments of cancer drugs in the United States and Europe. KN Vokinger, P Daniore, CWC Lee, AS Kesselheim, TJ Hwang Journal of Clinical Oncology 38 (15_suppl), 2006-2006, 2020 | | 2020 |
| Trust Your Gut: Glycosphingolipids from the Gut Commensal Bacteroides Fragilis and Their Unique Immunomodulatory Function to Colonic Invariant Natural Killer T Cells CWC Lee Harvard University, 2019 | | 2019 |
